Prenatal ethanol exposure programs an increased susceptibility of non-alcoholic fatty liver disease in female adult offspring rats

Toxicology and Applied Pharmacology

Volumn 274, Issue 2, 2014, Pages 263-273

  Shen, Lang ^a   Liu, Zhongfen ^a   Gong, Jun ^a   Zhang, Li ^a   Wang, Linlong ^b   Magdalou, Jacques ^c   Chen, Liaobin ^b   Wang, Hui ^a,d  

^a WUHAN UNIVERSITY   (China)

^b ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c Biopôle de l Université de Lorraine   (France)

^d WUHAN UNIVERSITY   (China)

Author keywords

Catch up growth; Glucocorticoid insulin like growth factor 1 axis; Non alcoholic fatty liver disease; Prenatal ethanol exposure; Two programming hypothesis

Indexed keywords

ALCOHOL; CARNITINE PALMITOYLTRANSFERASE I; CORTICOSTERONE; GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SOMATOMEDIN C; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRANSCRIPTION FACTOR FKHR; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; BODY WEIGHT; CATCH UP GROWTH; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DISEASE PREDISPOSITION; DOWN REGULATION; FEMALE; FETUS; FOOD INTAKE; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HYPERGLYCEMIA; INTRAUTERINE GROWTH RETARDATION; LIPID DIET; LIPID METABOLISM; LIPID OXIDATION; LIPOGENESIS; LIVER CELL; NONALCOHOLIC FATTY LIVER; NONHUMAN; PHENOTYPE; PRENATAL ETHANOL EXPOSURE; PRENATAL EXPOSURE; PROTEIN EXPRESSION; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84890878784     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.11.009     Document Type: Article

References (47)

1. Alisi A., Cianfarani S., Manco M., Agostoni C., Nobili V. Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment. Ann. Med. 2012, 44:29-40.
2. Arends N., Johnston L., Hokken-Koelega A., van Duijn C., de Ridder M., Savage M., Clark A. Polymorphism in the IGF-I gene: clinical relevance for short children born small for gestational age (SGA). J. Clin. Endocrinol. Metab. 2002, 87:2720.
3. Aros S., Mills J.L., Iniguez G., Avila A., Conley M.R., Troendle J., Cox C., Cassorla F. Effects of prenatal ethanol exposure on postnatal growth and the insulin-like growth factor axis. Horm. Res. Paediatr. 2011, 75:166-173.
4. Bedogni G., Miglioli L., Masutti F., Tiribelli C., Marchesini G., Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005, 42:44-52.
5. Cao L., Mao C., Li S., Zhang Y., Lv J., Jiang S., Xu Z. Hepatic insulin signaling changes: possible mechanism in prenatal hypoxia-increased susceptibility of fatty liver in adulthood. Endocrinology 2012, 153:4955-4965.
6. Carbone D.L., Zuloaga D.G., Hiroi R., Foradori C.D., Legare M.E., Handa R.J. Prenatal dexamethasone exposure potentiates diet-induced hepatosteatosis and decreases plasma IGF-I in a sex-specific fashion. Endocrinology 2012, 153:295-306.
7. Castells S., Mark E., Abaci F., Schwartz E. Growth retardation in fetal alcohol syndrome. Unresponsiveness to growth-promoting hormones. Dev. Pharmacol. Ther. 1981, 3:232-241.
8. Chen L., Nyomba B.L. Effects of prenatal alcohol exposure on glucose tolerance in the rat offspring. Metabolism 2003, 52:454-462.
9. Chen L., Nyomba B.L. Whole body insulin resistance in rat offspring of mothers consuming alcohol during pregnancy or lactation: comparing prenatal and postnatal exposure. J. Appl. Physiol. 2004, 96:167-172.
10. Choi G.Y., Tosh D.N., Garg A., Mansano R., Ross M.G., Desai M. Gender-specific programmed hepatic lipid dysregulation in intrauterine growth-restricted offspring. Am. J. Obstet. Gynecol. 2007, 196(477):e471-e477.
11. Cianfarani S., Germani D., Branca F. Low birthweight and adult insulin resistance: the "catch-up growth" hypothesis. Arch. Dis. Child. Fetal Neonatal Ed. 1999, 81:F71-F73.
12. Engelbregt M.J., van Weissenbruch M.M., Popp-Snijders C., Lips P., Delemarre-van de Waal H.A. Body mass index, body composition, and leptin at onset of puberty in male and female rats after intrauterine growth retardation and after early postnatal food restriction. Pediatr. Res. 2001, 50:474-478.
13. Fowden A.L. The insulin-like growth factors and feto-placental growth. Placenta 2003, 24:803-812.
14. Fu Q., McKnight R.A., Yu X., Wang L., Callaway C.W., Lane R.H. Uteroplacental insufficiency induces site-specific changes in histone H3 covalent modifications and affects DNA-histone H3 positioning in day 0 IUGR rat liver. Physiol. Genomics 2004, 20:108-116.
15. Gohlke J.M., Griffith W.C., Faustman E.M. A systems-based computational model for dose-response comparisons of two mode of action hypotheses for ethanol-induced neurodevelopmental toxicity. Toxicol. Sci. 2005, 86:470-484.
16. Greenfield V., Cheung O., Sanyal A.J. Recent advances in nonalcholic fatty liver disease. Curr. Opin. Gastroenterol. 2008, 24:320-327.
17. Gundogan F., Elwood G., Longato L., Tong M., Feijoo A., Carlson R.I., Wands J.R., de la Monte S.M. Impaired placentation in fetal alcohol syndrome. Placenta 2008, 29:148-157.
18. Hagiwara A., Cornu M., Cybulski N., Polak P., Betz C., Trapani F., Terracciano L., Heim M.H., Ruegg M.A., Hall M.N. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab. 2012, 15:725-738.
19. Hellstrom A., Jansson C., Boguszewski M., Olegard R., Laegreid L., Albertsson-Wikland K. Growth hormone status in six children with fetal alcohol syndrome. Acta Paediatr. 1996, 85:1456-1462.
20. Hernandez M.I., Mericq V. Metabolic syndrome in children born small-for-gestational age. Arq. Bras. Endocrinol. Metabol. 2011, 55:583-589.
21. Horton J.D., Shah N.A., Warrington J.A., Anderson N.N., Park S.W., Brown M.S., Goldstein J.L. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:12027-12032.
22. Jia Y., Cong R., Li R., Yang X., Sun Q., Parvizi N., Zhao R. Maternal low-protein diet induces gender-dependent changes in epigenetic regulation of the glucose-6-phosphatase gene in newborn piglet liver. J. Nutr. 2012, 142:1659-1665.
23. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., Ferrell L.D., Liu Y.C., Torbenson M.S., Unalp-Arida A., Yeh M., McCullough A.J., Sanyal A.J., Nonalcoholic Steatohepatitis Clinical Research N. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
24. Lane R.H., Kelley D.E., Gruetzmacher E.M., Devaskar S.U. Uteroplacental insufficiency alters hepatic fatty acid-metabolizing enzymes in juvenile and adult rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 280:R183-R190.
25. Levy-Marchal C., Czernichow P. Small for gestational age and the metabolic syndrome: which mechanism is suggested by epidemiological and clinical studies?. Horm. Res. 2006, 65(Suppl. 3):123-130.
26. Liang G., Chen M., Pan X.L., Zheng J., Wang H. Ethanol-induced inhibition of fetal hypothalamic-pituitary-adrenal axis due to prenatal overexposure to maternal glucocorticoid in mice. Exp. Toxicol. Pathol. 2011, 63:607-611.
27. Magee T.R., Han G., Cherian B., Khorram O., Ross M.G., Desai M. Down-regulation of transcription factor peroxisome proliferator-activated receptor in programmed hepatic lipid dysregulation and inflammation in intrauterine growth-restricted offspring. Am. J. Obstet. Gynecol. 2008, 199(271):e271-e275.
28. May P.A., Gossage J.P., Brooke L.E., Snell C.L., Marais A.S., Hendricks L.S., Croxford J.A., Viljoen D.L. Maternal risk factors for fetal alcohol syndrome in the Western Cape Province of South Africa: a population-based study. Am. J. Public Health 2005, 95:1190-1199.
29. Muhajarine N., D'Arcy C., Edouard L. Prevalence and predictors of health risk behaviours during early pregnancy: Saskatoon Pregnancy and Health Study. Can. J. Public Health 1997, 88:375-379.
30. Nammi S., Dembele K., Nyomba B.L. Increased 11beta-hydroxysteroid dehydrogenase type-1 and hexose-6-phosphate dehydrogenase in liver and adipose tissue of rat offspring exposed to alcohol in utero. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292:R1101-R1109.
31. Nobili V., Alisi A., Panera N., Agostoni C. Low birth weight and catch-up-growth associated with metabolic syndrome: a ten year systematic review. Pediatr. Endocrinol. Rev. 2008, 6:241-247.
32. O'Leary C.M. Fetal alcohol syndrome: diagnosis, epidemiology, and developmental outcomes. J. Paediatr. Child Health 2004, 40:2-7.
33. Pal-Bhadra M., Bhadra U., Jackson D.E., Mamatha L., Park P.H., Shukla S.D. Distinct methylation patterns in histone H3 at Lys-4 and Lys-9 correlate with up- & down-regulation of genes by ethanol in hepatocytes. Life Sci. 2007, 81:979-987.
34. Pantazis N.J., Dohrman D.P., Luo J., Goodlett C.R., West J.R. Alcohol reduces the number of pheochromocytoma (PC12) cells in culture. Alcohol 1992, 9:171-180.
35. Park S.H., Jeon W.K., Kim S.H., Kim H.J., Park D.I., Cho Y.K., Sung I.K., Sohn C.I., Keum D.K., Kim B.I. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J. Gastroenterol. Hepatol. 2006, 21:138-143.
36. Postic C., Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J. Clin. Invest. 2008, 118:829-838.
37. Qiu X.S., Huang T.T., Deng H.Y., Shen Z.Y., Ke Z.Y., Mei K.Y., Lai F. Effects of early nutrition intervention on IGF1, IGFBP3, intestinal development, and catch-up growth of intrauterine growth retardation rats. Chin. Med. Sci. J. 2004, 19:189-192.
38. Rai A.J., Kamath R.M., Gerald W., Fleisher M. Analytical validation of the GeXP analyzer and design of a workflow for cancer-biomarker discovery using multiplexed gene-expression profiling. Anal. Bioanal. Chem. 2009, 393:1505-1511.
39. Reinehr T., Kleber M., Toschke A.M. Small for gestational age status is associated with metabolic syndrome in overweight children. Eur. J. Endocrinol. 2009, 160:579-584.
40. Silveira V.M., Horta B.L. Birth weight and metabolic syndrome in adults: meta-analysis. Rev. Saude Publ. 2008, 42:10-18.
41. Tan Y., Liu J., Deng Y., Cao H., Xu D., Cu F., Lei Y., Magdalou J., Wu M., Chen L., Wang H. Caffeine-induced fetal rat over-exposure to maternal glucocorticoid and histone methylation of liver IGF-1 might cause skeletal growth retardation. Toxicol. Lett. 2012, 214:279-287.
42. Tze W.J., Friesen H.G., MacLeod P.M. Growth hormone response in fetal alcohol syndrome. Arch. Dis. Child. 1976, 51:703-706.
43. Williams R.J., Gloster S.P. Knowledge of fetal alcohol syndrome (FAS) among natives in Northern Manitoba. J. Stud. Alcohol 1999, 60:833-836.
44. Woods K.A., van Helvoirt M., Ong K.K., Mohn A., Levy J., de Zegher F., Dunger D.B. The somatotropic axis in short children born small for gestational age: relation to insulin resistance. Pediatr. Res. 2002, 51:76-80.
45. Xu D., Wu Y., Liu F., Liu Y.S., Shen L., Lei Y.Y., Liu J., Ping J., Qin J., Zhang C., Chen L.B., Magdalou J., Wang H. A hypothalamic-pituitary-adrenal axis-associated neuroendocrine metabolic programmed alteration in offspring rats of IUGR induced by prenatal caffeine ingestion. Toxicol. Appl. Pharmacol. 2012, 264:395-403.
46. Yamada M., Wolfe D., Han G., French S.W., Ross M.G., Desai M. Early onset of fatty liver in growth-restricted rat fetuses and newborns. Congenit. Anom. (Kyoto) 2011, 51:167-173.
47. Zhang L., Xu D., Zhang B., Liu Y., Chu F., Guo Y., Gong J., Zheng X., Chen L., Wang H. Prenatal food restriction induces a hypothalamic-pituitary-adrenocortical axis-associated neuroendocrine metabolic programmed alteration in adult offspring rats. Arch. Med. Res. 2013, 44:335-345.